Sarilumab

• Sarilumab efficacy and safety in adults with early polymyalgia rheumatica Pending
  2024-511296-15-00 Phase III 9 countries Sanofi-Aventis Recherche & Developpement
• The OASE study Pending
  2026-525221-21-01 Phase IV 1 country Aalborg University Hospital
• A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given with Either Cemiplimab, or Cemiplimab + Fianlimab, … Recruiting
  2022-501904-83-00 Phase I (FiH) 3 countries Regeneron Pharmaceuticals Inc.
• A Trial to Learn if Linvoseltamab is Safe and Works in Adults with Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis) Recruiting
  2023-507809-34-00 Phase I/II 2 countries Regeneron Pharmaceuticals Inc.
• The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study Recruiting
  2022-502021-18-00 Phase IV 5 countries Queen Mary University Of London
• Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other… Recruiting
  2024-510783-23-00 Phase I (FiH) 5 countries Regeneron Pharmaceuticals Inc.
• Study of clinical response, MRI progression, synovitis and changes in gene expression profiles in response to Sarilumab in patients with rhe… Recruiting
  2024-514201-61-00 Phase IV 1 country Cliniques Universitaires Saint-Luc
• A Repeated Dose-finding Study of Sarilumab in Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA) Recruiting
  2024-512701-11-00 Phase II 11 countries Sanofi-Aventis Recherche & Developpement
• RANDOMIZED CONTROLLED CLINICAL TRIAL EVALUATING METHOTREXATE OR LEFLUNOMIDE + TARGETED THERAPY VERSUS METHOTREXATE OR LEFLUNOMIDE + SULFASAL… Recruiting
  2024-516704-41-00 Phase III/IV 1 country Les Hopitaux Universitaires De Strasbourg

Showing 1–9 of 9 trials